This episode features an evidence-based dialogue with Professor Luke Clancy on contemporary tobacco control. The discussion critically analyses tobacco’s disease burden, cessation knowledge gaps in respiratory medicine, industry evolution toward novel nicotine products, adolescent neurodevelopmental risks of nicotine addiction, and missed opportunities in tobacco control during COVID-19.